Feraccru

RSS

ferric maltol

Authorised
This medicine is authorised for use in the European Union.

Overview

Feraccru is an iron-containing medicine used to treat iron deficiency (lack of iron) in adults.

Feraccru contains the active substance ferric maltol.

This EPAR was last updated on 23/02/2022

Authorisation details

Product details
Name
Feraccru
Agency product number
EMEA/H/C/002733
Active substance
ferric maltol
International non-proprietary name (INN) or common name
ferric maltol
Therapeutic area (MeSH)
Anemia, Iron-Deficiency
Anatomical therapeutic chemical (ATC) code
B03AB
Publication details
Marketing-authorisation holder
Norgine B.V.
Revision
16
Date of issue of marketing authorisation valid throughout the European Union
18/02/2016
Contact address

Antonio Vivaldistraat 150
1083 HP Amsterdam
Netherlands

Product information

09/02/2022 Feraccru - EMEA/H/C/002733 - IB/0042

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Antianemic preparations

Therapeutic indication

Feraccru is indicated in adults for the treatment of iron deficiency.

Assessment history

Related content

How useful was this page?

Add your rating
Average
1 rating
2 ratings